BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21512700)

  • 1. Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies.
    Francisco C; Gama S; Mendes F; Marques F; dos Santos IC; Paulo A; Santos I; Coimbra J; Gabano E; Ravera M
    Dalton Trans; 2011 Jun; 40(21):5781-92. PubMed ID: 21512700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper(II) complexes with tridentate pyrazole-based ligands: synthesis, characterization, DNA cleavage activity and cytotoxicity.
    Gama S; Mendes F; Marques F; Santos IC; Carvalho MF; Correia I; Pessoa JC; Santos I; Paulo A
    J Inorg Biochem; 2011 May; 105(5):637-44. PubMed ID: 21450266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel bis(thiosemicarbazones) of the 3,5-diacetyl-1,2,4-triazol series and their platinum(II) complexes: chemistry, antiproliferative activity and preliminary nephrotoxicity studies.
    Matesanz AI; Hernández C; Rodríguez A; Souza P
    Dalton Trans; 2011 Jun; 40(21):5738-45. PubMed ID: 21519595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
    Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
    Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours.
    Margiotta N; Ostuni R; Gandin V; Marzano C; Piccinonna S; Natile G
    Dalton Trans; 2009 Dec; (48):10904-13. PubMed ID: 20023921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions.
    Mügge C; Liu R; Görls H; Gabbiani C; Michelucci E; Rüdiger N; Clement JH; Messori L; Weigand W
    Dalton Trans; 2014 Feb; 43(8):3072-86. PubMed ID: 24169734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
    Ruiz J; Villa MD; Cutillas N; López G; de Haro C; Bautista D; Moreno V; Valencia L
    Inorg Chem; 2008 Jun; 47(11):4490-505. PubMed ID: 18447329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, carbohydrate- and DNA-binding studies of cationic 2,2':6',2''-terpyridineplatinum(II) complexes containing N- and S-donor boronic acid ligands.
    Hosseini SS; Bhadbhade M; Clarke RJ; Rutledge PJ; Rendina LM
    Dalton Trans; 2011 Jan; 40(2):506-13. PubMed ID: 21088793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs.
    Ravera M; Gabano E; Zanellato I; Fregonese F; Pelosi G; Platts JA; Osella D
    Dalton Trans; 2016 Mar; 45(12):5300-9. PubMed ID: 26903367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent on in vitro and in vivo tumor cell proliferation.
    Marzano C; Mazzega Sbovata S; Gandin V; Colavito D; Del Giudice E; Michelin RA; Venzo A; Seraglia R; Benetollo F; Schiavon M; Bertani R
    J Med Chem; 2010 Aug; 53(16):6210-27. PubMed ID: 20681543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.
    Porchia M; Benetollo F; Refosco F; Tisato F; Marzano C; Gandin V
    J Inorg Biochem; 2009 Dec; 103(12):1644-51. PubMed ID: 19822369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palladium(II) and platinum(II) bis(thiosemicarbazone) complexes of the 2,6-diacetylpyridine series with high cytotoxic activity in cisplatin resistant A2780cisR tumor cells and reduced toxicity.
    Matesanz AI; Leitao I; Souza P
    J Inorg Biochem; 2013 Aug; 125():26-31. PubMed ID: 23685347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, crystal structure, DNA-binding and cytotoxicity in vitro of novel cis-Pt(II) and trans-Pd(II) pyridine carboxamide complexes.
    Shi CY; Gao EJ; Ma S; Wang ML; Liu QT
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7250-4. PubMed ID: 21071219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance.
    Margiotta N; Natile G; Capitelli F; Fanizzi FP; Boccarelli A; De Rinaldis P; Giordano D; Coluccia M
    J Inorg Biochem; 2006 Nov; 100(11):1849-57. PubMed ID: 16959321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells.
    Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U
    J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New 7-azaindole palladium and platinum complexes: crystal structures and theoretical calculations. In vitro anticancer activity of the platinum compounds.
    Ruiz J; Rodríguez V; de Haro C; Espinosa A; Pérez J; Janiak C
    Dalton Trans; 2010 Apr; 39(13):3290-301. PubMed ID: 20449459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP.
    Pantoja E; Gallipoli A; van Zutphen S; Komeda S; Reddy D; Jaganyi D; Lutz M; Tooke DM; Spek AL; Navarro-Ranninger C; Reedijk J
    J Inorg Biochem; 2006 Dec; 100(12):1955-64. PubMed ID: 17083978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structural characterization, and pro-apoptotic activity of 1-indanone thiosemicarbazone platinum(II) and palladium(II) complexes: potential as antileukemic agents.
    Gómez N; Santos D; Vázquez R; Suescun L; Mombrú A; Vermeulen M; Finkielsztein L; Shayo C; Moglioni A; Gambino D; Davio C
    ChemMedChem; 2011 Aug; 6(8):1485-94. PubMed ID: 21608131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.